Latest Bristol-Myers Squibb Stories
NUSSLOCH, Germany, August 7, 2014 /PRNewswire/ -- - Leica Biosystems announces a collaboration with Bristol-Myers Squibb to develop companion diagnostic
OTTAWA, July 31, 2014 /CNW/ - Health Canada today released the July 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue includes an article on the anti-cancer
Global BioPharmaceutical Leader Leases an Additional 61,000 Square Feet to Grow Its Presence and Research Capabilities in the Bay Area SAN DIEGO, July 24, 2014 /PRNewswire/ -- BioMed
CLARK, N.J., July 10, 2014 /PRNewswire/ -- GEP, a leading provider of procurement and supply chain solutions to Fortune 500 and Global 2000 enterprises worldwide, is pleased to announce that
On July 1, the FDA published that 6 lots of Coumadin (Warfarin Sodium) for Injection, 5 mg single-use vials, by Bristol-Myers Squibb, are recalled due to the presence of visible particulate matter.
LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.
SAN DIEGO, June 25, 2014 /PRNewswire/ -- Concortis Biosystems, Inc.
- The act of sweetening by admixture of some saccharine substance.